Company intelligence / Profile preview

Marca

Ownership: Private
Development stage: Other

Overview

Marca is a pharmaceutical company focused on the development, manufacturing, and commercialization of a diverse range of healthcare products. The company specializes in providing high-quality generic and branded formulations across various therapeutic areas, including anti-infectives, gastrointestinal health, and analgesics. Marca operates with a strong emphasis on meeting international quality standards to ensure the safety and efficacy of its medicinal offerings. By leveraging its manufacturing capabilities, the company aims to improve patient access to essential medicines in its target markets.

Therapeutic areas: Infectious DiseasesNeurologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Marca.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marca.

Explore the full profile